Ubisoft Entertainment SA (4UBI)

Overview

Universal Biosensors, Inc. is a prominent company specialized in the design and development of electrochemical cells, widely recognized as strips, which are integral to the operation of point-of-use devices across various industries including healthcare, wine, food, and agriculture. With a global footprint that spans Australia, the Americas, Europe, and beyond, Universal Biosensors focuses on offering innovative solutions that cater to the evolving needs of its diverse clientele. Originating in 2001 and headquartered in Rowville, Australia, the company has demonstrated a sustained commitment to advancing the diagnostics and monitoring sector through its pioneering technologies and products.

Products and Services

The product portfolio and service offerings of Universal Biosensors are tailored to meet a broad spectrum of industry requirements, ensuring high standards of quality and reliability:

• Prothrombin Time International Normalized Ratio (PT INR) coagulation test strips: These test strips are engineered for use in monitoring the effects of the anticoagulant therapy, warfarin. Their precision aids healthcare providers in adjusting warfarin doses to optimize patient care.
• Xprecia Stride and Xprecia Prime medical devices: Specifically designed for coagulation testing, these devices offer state-of-the-art solutions to enhance patient safety and treatment outcomes by providing quick and reliable test results for healthcare professionals.
• Sentia wine testing products: Catering to the wine industry, Sentia offers an array of testing products, including tests for free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. These allow wine producers to maintain quality control and ensure the excellence of their products.
• Non-diagnostic laboratory services: Beyond its manufacturing capabilities, Universal Biosensors provides a range of non-diagnostic laboratory services designed to support research and development activities across different sectors.
• Coagulation testing services: The company leverages its expertise in coagulation testing to offer comprehensive testing services, aiding in the assessment and monitoring of various conditions that require coagulation analysis.
• License agreement with LifeScan Global Corporation: This partnership underscores Universal Biosensors' commitment to expanding its technological horizons by developing a specialized test strip and meter aimed at detecting and monitoring diabetes in non-humans, thereby broadening its impact in the veterinary healthcare sector.